Larvol Delta - Axelia-Oncology-Announces-a-Clinical-Supply-Agreement-with-Regeneron-for-Trial-Evaluating-AXA042-in-Combination-with-Libtayo-cemiplimab

AXA-042 - Axelia Oncology

https://axeliaoncology.com/wp-content/uploads/2025/02/Press_release_Drug_supply_Final-1.pdf

Feb 14, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next